G. Kenneth Lloyd
Chief Tech/Sci/R&D Officer chez BEYONDSPRING INC.
Fortune : 145 088 $ au 31/03/2024
Profil
G.
Kenneth Lloyd is the founder of GKOL, Inc. He is currently the Chief Scientific Officer at BeyondSpring, Inc. Dr. Lloyd received his undergraduate and graduate degrees from McGill University and his doctorate from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEYONDSPRING INC.
0,10% | 01/03/2023 | 40 641 ( 0,10% ) | 145 088 $ | 31/03/2024 |
Postes actifs de G. Kenneth Lloyd
| Sociétés | Poste | Début |
|---|---|---|
| BEYONDSPRING INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
Anciens postes connus de G. Kenneth Lloyd
| Sociétés | Poste | Fin |
|---|---|---|
| Dalian Wanchun Biotechnology Co. Ltd. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 29/04/2013 |
A.E. Wyeth & Co.
 A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The private company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Chief Tech/Sci/R&D Officer | - |
| Sanofi SA | Corporate Officer/Principal | - |
Verne Mendel Medical Corp.
 Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Director/Board Member | - |
Formation de G. Kenneth Lloyd
| McGill University | Graduate Degree |
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
A.E. Wyeth & Co.
A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The private company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Commercial Services |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
| Wyeth-Ayerst Research | |
| Sanofi SA | Health Technology |
| GKOL, Inc. | |
Verne Mendel Medical Corp.
Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. |
